Back

Anticoagulation can be stopped after successful catheter ablation of AF in patients with CHADSVASC ≥2 risk of thromboembolism - Rebuttal CON

18 March 2018 (14:35 - 14:40)
Organised by:
Congress Presentation Part of: Tough decisions in anticoagulation in atrial fibrillation Stroke Prevention in Cardioversion EHRA Premium Access EHRA 2018

11 More presentations in this session

Presentation thumbnail
Opening question
Slides Video
Presentation thumbnail
Anticoagulation can be stopped after successful catheter ablation of AF in patients with CHADSVASC ≥2 risk of thromboembolism- PRO
Doctor S. Themistoclakis (Venice, IT)
Slides Video
Presentation thumbnail
Anticoagulation can be stopped after successful catheter ablation of AF in patients with CHADSVASC ≥2 risk of thromboembolism - CON
Professor T. Potpara (Belgrade, RS)
Slides Video
Presentation thumbnail
Anticoagulation can be stopped after successful catheter ablation of AF in patients with CHADSVASC ≥2 risk of thromboembolism - Rebuttal PRO
Video
Presentation thumbnail
Chairperson conclusion & Closing question
Slides Video

Access the full session

Session thumbnail
Tough decisions in anticoagulation in atrial fibrillation

The Event

Event poster

EHRA 2018

18 March 2018 14:35 CET
You may be interested in
thumbnail
Congress Presentation
Balancing stroke and bleeding risks: the impact of stopping anticoagulation after aAF ablation - a systematic review and meta-analysis
1 September 2025
thumbnail
Webinar
Key updates from the EHRA/HRS/APHRS/LAHRS 2024 Expert Consensus Statement on Atrial Fibrillation Ablation
10 February 2025
thumbnail
Congress Presentation
Incidence of left atrial thrombi in patients with atrial fibrillation and low thromboembolic risk: do we always need transesophageal echocardiography before rhythm control therapy?
13 April 2026
thumbnail
Congress Session
Oral anticoagulation in subclinical atrial fibrillation
31 March 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources